On Friday, Allergan PLC(NYSE:AGN)’s shares declined -1.03% to $293.98.
Allergan plc (AGN) a leading global pharmaceutical company, declared that Brent Saunders, CEO and President of Allergan, will provide an overview and update of the Company’s business at the Morgan Stanley Global Healthcare Conference 2015 in New York, NY.
The presentation will take place on Thursday, September 17, 2015 at 10:35 AM Eastern Time at the Grand Hyatt New York, 109 East 42nd Street, New York, NY 10017.
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment provides patented and off-patent trademarked pharmaceutical products primarily under the Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo Loestrin Fe, and Minastrin 24 Fe brands. The North American Generics and International segment develops, manufactures, and sells generic, branded generic, and OTC pharmaceutical products.
Allscripts Healthcare Solutions Inc(NASDAQ:MDRX)’s shares dropped -1.14% to $13.00.
Allscripts Healthcare Solutions, Inc. (MDRX) declared its financial results for the three and six months ended June 30, 2015.
Second-Quarter and Six-Month Bookings Highlights:
Bookings(1) were $260 million, a second-quarter record, contrast with $233 million in the second quarter of 2014, an 11 percent enhance. A higher mix of new client sales across Allscripts portfolio, counting acute solutions in both international and domestic markets, ambulatory and payer life sciences solutions, drove second quarter 2015 bookings performance on a year-over-year basis.
About 65 percent of second-quarter bookings related to software delivery, while the remaining 35 percent related to sales of client services. This compares with 58 and 42 percent of bookings attributable to these revenue categories, respectively, in the second quarter of 2014. Software delivery bookings raised 25 percent in the second quarter, year-over-year.
Allscripts Healthcare Solutions, Inc. provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The Clinical and Financial Solutions segment provides integrated clinical software applications, financial and information solutions, and related installation and maintenance services, counting EHR related software, financial and practice administration software, related installation and training services, and electronic claims administration services.
At the end of Friday’s trade, Five Below Inc (NASDAQ:FIVE)‘s shares dipped -1.10% to $34.11.
RBC Capital analyst Scot Ciccarelli initiated coverage of Five Below Inc ( FIVE) with a Buy rating and $48 price target. The analyst believes that the company has “huge” potential for unit growth and offers high ROI. The stock is ideal for investors seeking long-term growth.
Five Below is predictable to expand its store base by about 20 percent in 2015 and 2016, with a growth rate of 15-20 percent over the next several years. The company intends of grow its stores to about 2,000 locations over the longer term. This means that there is potential to grow the current store base by almost 500 percent, which would be the biggest unit expansion potential in Hardlines Retail.
The analyst also anticipates Five Below to be able to attain an “impressive” ROI of 110-120 percent within the first 12 months of operation of any store. For its new store classes during 2011-2014, the company was able to generate 4-wall ROI of over 150 percent, indicating a payback period of just 8 months.
Five Below, Inc. operates as a specialty value retailer in the United States. It offers accessories, counting novelty socks, sunglasses, jewelry, scarves, gloves, hair accessories, athletic tops and bottoms, and t-shirts, in addition to beauty products comprising nail polish, lip gloss, fragrance, and branded cosmetics; and items used to complete and personalize living space, counting glitter lamps, posters, frames, fleece blankets, pillows, candles, incense and related items, and storage options for the customer’s room and locker.
HCA Holdings Inc (NYSE:HCA), ended its Friday’s trading session with -1.15% loss, and closed at $85.41.
HCA (HCA) presented the 2014 HCA Awards of Distinction to five recipients at a ceremony in Nashville.
The HCA Awards of Distinction comprise the Frist Humanitarian Awards, which annually honor an employee, physician and volunteer, each of whom embody HCA co-founder Dr. Thomas Frist Sr.’s volunteer spirit and compassion. The HCA Awards of Distinction also comprise the HCA Excellence in Nursing Awards, a new honor that celebrates HCA nurses who promote professional mentorship and compassionate care.
HCA Holdings, Inc., through its auxiliaries, provides health care services in the United States. It operates general, acute care hospitals that offer medical and surgical services, counting inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
